CTCX
Price:
$0.1973
Market Cap:
$2.39M
Carmell Therapeutics Corporation focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.
Industry
Biotechnology
IPO Date
2021-09-23
Stock Exchange
NASDAQ
Ticker
CTCX
According to Carmell Therapeutics Corporation’s latest financial reports and current stock price. The company's current PE Ratio is 0.41. This represents a change of -120.87% compared to the average of -1.97 of the last 4 quarters.
The mean historical PE Ratio of Carmell Therapeutics Corporation over the last ten years is -14.18. The current 0.41 PE Ratio has changed -389.94% with respect to the historical average. Over the past ten years (40 quarters), CTCX's PE Ratio was at its highest in in the June 2023 quarter at 160.33. The PE Ratio was at its lowest in in the June 2021 quarter at -7395.79.
Average
-14.18
Median
-13.40
Minimum
-29.35
Maximum
-0.56
Discovering the peaks and valleys of Carmell Therapeutics Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual PE Ratio = -0.56
Minimum Annual Increase = -89.02%
Minimum Annual PE Ratio = -29.35
Year | PE Ratio | Change |
---|---|---|
2024 | -0.56 | -89.02% |
2023 | -5.12 | -76.35% |
2022 | -21.67 | -26.19% |
The current PE Ratio of Carmell Therapeutics Corporation (CTCX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-9.12
5-year avg
-14.18
10-year avg
-14.18
Carmell Therapeutics Corporation’s PE Ratio is
Company | PE Ratio | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Carmell Therapeutics Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Carmell Therapeutics Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Carmell Therapeutics Corporation's PE Ratio?
How is the PE Ratio calculated for Carmell Therapeutics Corporation (CTCX)?
What is the highest PE Ratio for Carmell Therapeutics Corporation (CTCX)?
What is the 3-year average PE Ratio for Carmell Therapeutics Corporation (CTCX)?
What is the 5-year average PE Ratio for Carmell Therapeutics Corporation (CTCX)?
How does the current PE Ratio for Carmell Therapeutics Corporation (CTCX) compare to its historical average?